NL7907244A - Als geneesmiddel dienende tablet voor de perorale applicatie en een werkwijze voor de bereiding daarvan. - Google Patents

Als geneesmiddel dienende tablet voor de perorale applicatie en een werkwijze voor de bereiding daarvan. Download PDF

Info

Publication number
NL7907244A
NL7907244A NL7907244A NL7907244A NL7907244A NL 7907244 A NL7907244 A NL 7907244A NL 7907244 A NL7907244 A NL 7907244A NL 7907244 A NL7907244 A NL 7907244A NL 7907244 A NL7907244 A NL 7907244A
Authority
NL
Netherlands
Prior art keywords
tablet
active compound
tablets
silicic acid
water
Prior art date
Application number
NL7907244A
Other languages
English (en)
Dutch (nl)
Original Assignee
Beiersdorf Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Beiersdorf Ag filed Critical Beiersdorf Ag
Publication of NL7907244A publication Critical patent/NL7907244A/nl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/141—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
    • A61K9/143—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2009—Inorganic compounds

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Inorganic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)
NL7907244A 1978-10-18 1979-09-28 Als geneesmiddel dienende tablet voor de perorale applicatie en een werkwijze voor de bereiding daarvan. NL7907244A (nl)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE2845326A DE2845326C2 (de) 1978-10-18 1978-10-18 Verwendung einer spezifischen mikrodispersen, amorphen, porösen Kieselsäure zur Herstellung von Digoxin enthaltenden Tabletten mit stark beschleunigter Wirkstoff-Freisetzung
DE2845326 1978-10-18

Publications (1)

Publication Number Publication Date
NL7907244A true NL7907244A (nl) 1980-04-22

Family

ID=6052475

Family Applications (1)

Application Number Title Priority Date Filing Date
NL7907244A NL7907244A (nl) 1978-10-18 1979-09-28 Als geneesmiddel dienende tablet voor de perorale applicatie en een werkwijze voor de bereiding daarvan.

Country Status (14)

Country Link
US (1) US4254099A (de)
JP (1) JPS5555113A (de)
AT (1) AT371712B (de)
AU (1) AU523794B2 (de)
BE (1) BE879487A (de)
CA (1) CA1125656A (de)
CH (1) CH640738A5 (de)
DE (1) DE2845326C2 (de)
ES (1) ES485399A0 (de)
FR (1) FR2439018A1 (de)
GB (1) GB2033225B (de)
NL (1) NL7907244A (de)
SE (1) SE445295B (de)
ZA (1) ZA795530B (de)

Families Citing this family (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1146866A (en) * 1979-07-05 1983-05-24 Yamanouchi Pharmaceutical Co. Ltd. Process for the production of sustained release pharmaceutical composition of solid medical material
JPS56152416A (en) * 1980-04-25 1981-11-26 Tsumura Juntendo Inc Preparation of chinese herbal remedy tablet
DE3263932D1 (en) * 1981-11-28 1985-07-04 Boehringer Mannheim Gmbh Guar gum preparation forms for oral administration
US4581232A (en) * 1983-07-20 1986-04-08 Warner-Lambert Company Magnesium trisilicate suitable for preparation of medicament adsorbates
GB8413191D0 (en) * 1984-05-23 1984-06-27 Beecham Group Plc Pharmaceutical composition
US4617294A (en) * 1985-04-22 1986-10-14 Ppg Industries, Inc. Animal feed supplement
US5310572A (en) * 1987-02-03 1994-05-10 Dow Corning Corporation Process for forming a coated active agent-containing article
IT1216570B (it) * 1988-04-08 1990-03-08 Vectorpharma Int Composizione farmaceutiche a rilascio controllato e procedimento per la loro preparazione.
US5039699A (en) * 1989-03-27 1991-08-13 Lederle (Japan), Ltd. Anti-peptic ulcer agent
JPH03109332A (ja) * 1989-09-21 1991-05-09 Shiseido Co Ltd 薬剤組成物
GB9025251D0 (en) * 1990-11-20 1991-01-02 Solomon Montague C Nifedipine dosage forms
US5629016A (en) * 1991-01-30 1997-05-13 Glaxo Wellcome Inc. Water-dispersible tablets
AU653203B2 (en) * 1991-01-30 1994-09-22 Wellcome Foundation Limited, The Water-dispersible tablets
US5698226A (en) * 1993-07-13 1997-12-16 Glaxo Wellcome Inc. Water-dispersible tablets
JP4064476B2 (ja) * 1996-03-29 2008-03-19 エラワン ファーマスーティカル リサーチ アンドラボラトリー カンパニー リミテッド 二酸化珪素を有する球状凝集した澱粉
GB9720061D0 (en) * 1997-09-19 1997-11-19 Crosfield Joseph & Sons Metal compounds as phosphate binders
CA2311734C (en) * 2000-04-12 2011-03-08 Bristol-Myers Squibb Company Flash-melt oral dosage formulation
HUP0401391A3 (en) * 2001-05-01 2009-06-29 Pfizer Prod Inc Method for manufacturing a low dose pharmaceutical composition having uniform drug distribution and potency and the pharmaceutical compositin
TWI324074B (en) * 2001-10-09 2010-05-01 Bristol Myers Squibb Co Flashmelt oral dosage formulation
MY142989A (en) * 2004-03-10 2011-02-14 Bayer Schering Pharma Ag Stabilised supersaturated solids of lipophilic drugs
NZ564789A (en) * 2005-07-22 2010-07-30 Myriad Genetics Inc High drug load formulations and dosage forms
MY157620A (en) 2006-01-31 2016-06-30 Cytochroma Dev Inc A granular material of a solid water-soluble mixed metal compound capable of binding phosphate
BRPI0807581A2 (pt) 2007-02-23 2014-07-01 Gilead Science Inc Moduladores de propriedades farmacocinéticas de produtos terapêuticos
GB0714670D0 (en) * 2007-07-27 2007-09-05 Ineos Healthcare Ltd Use
GB0720220D0 (en) * 2007-10-16 2007-11-28 Ineos Healthcare Ltd Compound
EA022950B1 (ru) * 2008-05-02 2016-03-31 Джилид Сайэнс, Инк. Применение частиц носителя диоксида кремния для улучшения технологических характеристик фармацевтического агента
GB0913525D0 (en) 2009-08-03 2009-09-16 Ineos Healthcare Ltd Method
GB201001779D0 (en) 2010-02-04 2010-03-24 Ineos Healthcare Ltd Composition
CN105050708A (zh) * 2012-11-14 2015-11-11 格雷斯公司 含有生物活性材料与无序无机氧化物的组合物

Family Cites Families (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR541197A (fr) * 1920-01-08 1922-07-24 Lilly Co Eli Procédé d'enrobage de remèdes et en particulier d'alcaloîdes d'ipéca de manière à ce qu'ils puissent être administrés par la bouche et absorbés par l'intestin
US2038694A (en) * 1930-10-15 1936-04-28 Davision Chemical Corp Medicament
US2698822A (en) * 1951-04-28 1955-01-04 Fougera & Co Inc E Cardiac glycoside buccal composition
US2820741A (en) * 1954-04-29 1958-01-21 Abbott Lab Aluminum aspirin granulation and method for making
US2857313A (en) * 1956-03-27 1958-10-21 Ciba Pharm Prod Inc Self-lubricating granulation
US3034911A (en) * 1959-03-25 1962-05-15 Nat Starch Chem Corp Tablet disintegrants
NL135732A (de) * 1960-11-17
US3148124A (en) * 1962-06-12 1964-09-08 William E Gaunt Method of preparing sustained release pharmaceutical tablets
DE1228029C2 (de) * 1964-05-09 1973-05-17 Merck Ag E Verfahren zur Herstellung von Tabletten durch Pressen von Pulvergemischen ohne vorhergehende Granulation
US3400197A (en) * 1965-01-26 1968-09-03 Robins Co Inc A H Compressible sustained release pharmaceutical tablet lipid-colloidal silica gel matrix fragment granules
DE1492034A1 (de) * 1965-05-18 1969-02-20 Merck Ag E Verfahren zur Herstellung fester haltbarer Zubereitungen von empfindlichen,in Wasser schwer loeslichen Wirkstoffen,vorzugsweise Arzneimitteln
NL6906980A (de) * 1968-05-22 1969-11-25
US3696091A (en) * 1970-06-03 1972-10-03 Boehringer Sohn Ingelheim Novel cardiac-active principles of the cardenolide glycoside class
US3632778A (en) * 1970-06-10 1972-01-04 Hoffmann La Roche Tablets containing l-dopa
US3725556A (en) * 1970-11-12 1973-04-03 D Hanssen Method of manufacturing rapidly disintegrating pharmaceutical tablets
US3908003A (en) * 1971-07-02 1975-09-23 American Home Prod Enrobed solid hydrophobic tableting lubricants and compositions
US3923969A (en) * 1973-06-12 1975-12-02 Battelle Institut E V Carrier system for a drug with sustained release
US3929996A (en) * 1973-06-29 1975-12-30 Interx Research Corp Pharmaceutical compositions containing a digoxin complex
US3884905A (en) * 1974-05-02 1975-05-20 Interx Research Corp Pro-drug forms of digoxin
US3946110A (en) * 1974-05-30 1976-03-23 Peter, Strong Research And Development Company, Inc. Medicinal compositions and methods of preparing the same
US4151273A (en) * 1974-10-31 1979-04-24 The Regents Of The University Of California Increasing the absorption rate of insoluble drugs
US4013785A (en) * 1975-03-21 1977-03-22 Bristol-Myers Company Apap tablet containing fumed silica and process for manufacturing same
US4143129A (en) * 1975-10-11 1979-03-06 Lilly Industries Limited Cephalexin tablets
US4021546A (en) * 1976-03-08 1977-05-03 Interx Research Corporation Pro-drug forms of digoxin and method of preparing and using same
US4202888A (en) * 1976-07-12 1980-05-13 Kali-Chemie Pharma Gmbh. Readily enterally absorbable pharmaceutical compositions of cardiac glycosides and preparation thereof
US4147768A (en) * 1976-09-13 1979-04-03 Interx Research Corporation Enteric coated digoxin and therapeutic use thereof

Also Published As

Publication number Publication date
BE879487A (fr) 1980-02-15
ES8100077A1 (es) 1980-11-01
ATA675979A (de) 1982-12-15
SE7907527L (sv) 1980-04-19
AT371712B (de) 1983-07-25
GB2033225A (en) 1980-05-21
CA1125656A (en) 1982-06-15
AU523794B2 (en) 1982-08-12
GB2033225B (en) 1983-06-15
SE445295B (sv) 1986-06-16
CH640738A5 (de) 1984-01-31
ZA795530B (en) 1980-09-24
ES485399A0 (es) 1980-11-01
FR2439018B1 (de) 1983-03-04
DE2845326C2 (de) 1985-05-23
AU5178979A (en) 1980-04-24
DE2845326A1 (de) 1980-04-24
FR2439018A1 (fr) 1980-05-16
US4254099A (en) 1981-03-03
JPS5555113A (en) 1980-04-22

Similar Documents

Publication Publication Date Title
NL7907244A (nl) Als geneesmiddel dienende tablet voor de perorale applicatie en een werkwijze voor de bereiding daarvan.
DK175138B1 (da) Fast dihydrocodeinpræparat med reguleret afgivelse
DE69902893T2 (de) Schnellauflösende efavirenz-kapseln oder tabletten durch verwendung von super-zersetzern
EP0188040B1 (de) Feste Zubereitung mit langsamer Freisetzung
JPS61251617A (ja) １つ又はそれ以上の活性成分を液に調整放出する組成物及びその調整方法
JPS63162627A (ja) 徐放性医薬製剤
KR20100012867A (ko) 타다라필을 포함하는 고체 제형
Prakhar et al. A comprehensive review on sustained release matrix tablets: a promising dosage form
Posey-Dowty et al. Zero-order release formulations using a novel cellulose ester
WO2006115770A2 (en) Orally disintegrating pharmaceutical tablet formulations of olanzapine
CN105828826B (zh) 含有托格列净的固体制剂及其生产方法
BE1006002A4 (fr) Composition a base de trimebutine a liberation prolongee et son procede de preparation.
JPS6087217A (ja) 一定放出速度の固体調剤テオフイリン配合物
JP4367723B2 (ja) 水難溶性成分を配合した固形剤
WO2020131784A1 (en) A sustained release composition comprising a methylcellulose
CN101491523A (zh) 含微粉化格列喹酮的组合物
KR20150096787A (ko) Ｎ-[5-[2-(3,5-디메톡시페닐)에틸]-2ｈ-피라졸-3-일]-4-[(3ｒ,5ｓ)-3,5-디메틸피페라진-1-일]벤즈아미드의 약학 제제
CN103768068A (zh) 一种波生坦药物组合物
CN112516097B (zh) 一种苯磺酸左旋氨氯地平组合物
CN116421595B (zh) 一种达格列净药物组合物及制备方法和应用
WO1990004980A1 (en) Drug composition
RU2681649C1 (ru) Композиция на основе празиквантеля для лечения описторхоза
KR20190050784A (ko) 테소펜신 조성물
RU2726637C1 (ru) Фармацевтическая композиция и способ ее получения
Chincholikar et al. FORMULATION DEVELOPMENT AND EVALUATION OF ONCE DAILY SUSTAINED RELEASE METFORMIN HYDROCHLORIDE TABLETS

Legal Events

Date Code Title Description
BA A request for search or an international-type search has been filed
BB A search report has been drawn up
BC A request for examination has been filed
A85 Still pending on 85-01-01
BV The patent application has lapsed